GPT Healthcare Limited is one of the key regional corporate healthcare providers in Eastern India in terms of the number of beds and hospitals as of Fiscal Year 2023 (Source: CRISIL Report). It operates a chain of mid-sized full-service multispecialty hospitals under a recognized brand, offering integrated healthcare services with a focus on secondary and tertiary care. As of June 30, 2023, the company manages four hospitals with a total capacity of 561 beds. These hospitals provide a comprehensive range of healthcare services across over 35 specialties and super specialties, including internal medicine, nephrology (including renal transplants), general and laparoscopic surgery, gynaecology, critical care, orthopaedics, cardiology, neurology, neurosurgery, paediatrics, and neonatology, among others. Each facility also offers integrated diagnostic services and pharmacies for patients.
GPT Healthcare Limited is one of the key regional corporate healthcare providers in Eastern India in terms of the number of beds and hospitals as of Fiscal Year 2023 (Source: CRISIL Report). It operates a chain of mid-sized full-service multispecialty hospitals under a recognized brand, offering integrated healthcare services with a focus on secondary and tertiary care. As of June 30, 2023, the company manages four hospitals with a total capacity of 561 beds. These hospitals provide a comprehensive range of healthcare services across over 35 specialties and super specialties, including internal medicine, nephrology (including renal transplants), general and laparoscopic surgery, gynaecology, critical care, orthopaedics, cardiology, neurology, neurosurgery, paediatrics, and neonatology, among others. Each facility also offers integrated diagnostic services and pharmacies for patients. The company strategically focuses on the under-penetrated healthcare market in Eastern India, with a presence in three cities, which has given them insights into regional nuances, patient culture, and the mindset of medical professionals, while addressing the shortage of quality and affordable healthcare. This approach has enabled the company to achieve strong financial performance, with revenue from operations (excluding COVID) growing at a CAGR of 53.87% from Fiscal Year 2021 to Fiscal Year 2023, and a return on capital employed (ROCE) of 26.09% for Fiscal Year 2023.
Show More